Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 1
1993 2
1994 1
1995 2
1996 1
1997 6
1998 4
1999 1
2000 1
2003 1
2004 1
2006 1
2007 5
2008 2
2009 5
2010 3
2011 4
2012 3
2013 5
2014 3
2015 7
2016 6
2017 5
2018 6
2019 2
2020 2
2021 3
2022 6
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
Coassin M, De Maria M, Mastrofilippo V, Braglia L, Cimino L, Sartori A, Fontana L. Coassin M, et al. Adv Ther. 2019 Oct;36(10):2712-2722. doi: 10.1007/s12325-019-01076-4. Epub 2019 Sep 3. Adv Ther. 2019. PMID: 31482510 Clinical Trial.
PURPOSE: To compare the efficacy of bromfenac 0.09% and dexamethasone 0.1% in the treatment of anterior chamber inflammation after uncomplicated cataract surgery. ...Mean macular thickness was similar in both the dexamethasone and bromfenac arms at 1 month. CONCLUSI …
PURPOSE: To compare the efficacy of bromfenac 0.09% and dexamethasone 0.1% in the treatment of anterior chamber inflammation after un …
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C, Salsini G, Perri P. Campa C, et al. Curr Eye Res. 2018 Mar;43(3):362-367. doi: 10.1080/02713683.2017.1396615. Epub 2017 Nov 9. Curr Eye Res. 2018. PMID: 29120255 Clinical Trial.
Patients who underwent routine cataract surgery with intraocular lens (IOL) implant were randomly divided into three groups receiving either bromfenac or nepafenac in association with dexamethasone or dexamethasone alone (control group) postoperatively. ...At 1 week, the n …
Patients who underwent routine cataract surgery with intraocular lens (IOL) implant were randomly divided into three groups receiving either …
Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
Flaxel C, Schain MB, Hamon SC, Francis PJ. Flaxel C, et al. Retina. 2012 Mar;32(3):417-23. doi: 10.1097/IAE.0b013e318229b0af. Retina. 2012. PMID: 21862953 Clinical Trial.
PURPOSE: To evaluate whether bromfenac eyedrops and ranibizumab intravitreal injections would provide added efficacy over ranibizumab alone. ...Patients receiving bromfenac self-administered 1 drop twice a day for 12 months. Patients were followed for 12 months. ...
PURPOSE: To evaluate whether bromfenac eyedrops and ranibizumab intravitreal injections would provide added efficacy over ranibizumab …
The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Giannaccare G, Finzi A, Sebastiani S, Greco F, Versura P, Campos EC. Giannaccare G, et al. Curr Eye Res. 2018 Dec;43(12):1445-1453. doi: 10.1080/02713683.2018.1501489. Epub 2018 Jul 27. Curr Eye Res. 2018. PMID: 30009640 Clinical Trial.
CONCLUSION: The addition of diclofenac or bromfenac ophthalmic solutions contributed to further reduce both inflammation and cystoid macular edema after cataract surgery compared to steroid-antibiotic combination alone. Diclofenac appeared to be more effective in reducing …
CONCLUSION: The addition of diclofenac or bromfenac ophthalmic solutions contributed to further reduce both inflammation and cystoid …
Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Henderson BA, Gayton JL, Chandler SP, Gow JA, Klier SM, McNamara TR; Bromfenac Ophthalmic Solution (Bromday) Once Daily Study Group. Henderson BA, et al. Ophthalmology. 2011 Nov;118(11):2120-7. doi: 10.1016/j.ophtha.2011.04.035. Epub 2011 Jul 16. Ophthalmology. 2011. PMID: 21762992 Clinical Trial.
PURPOSE: To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution (bromfenac) 0.09% dosed once daily for the treatment of ocular inflammation and pain after cataract surgery with posterior chamber intraocular lens implantation. ...The proportion o …
PURPOSE: To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution (bromfenac) 0.09% dosed once daily for th …
Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery.
Boström AA, Forbes JA, Adolfsson C, Beaver WT, Bell WE. Boström AA, et al. Pharmacotherapy. 1994 May-Jun;14(3):305-13. Pharmacotherapy. 1994. PMID: 7937271 Clinical Trial.
STUDY OBJECTIVES: To determine the relative analgesic potency and adverse effect liability of bromfenac 25, 50, and 100 mg, and ibuprofen 200 and 400 mg in the treatment of postoperative pain after orthopedic surgery. ...Adverse effects for both bromfenac and ibupro …
STUDY OBJECTIVES: To determine the relative analgesic potency and adverse effect liability of bromfenac 25, 50, and 100 mg, and ibupr …
Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR; Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Donnenfeld ED, et al. Ophthalmology. 2007 Sep;114(9):1653-62. doi: 10.1016/j.ophtha.2006.12.029. Epub 2007 Apr 19. Ophthalmology. 2007. PMID: 17445902 Clinical Trial.
The median time to resolution of ocular pain was 2 days (bromfenac) versus 5 days (placebo) (P<0.0001). Numbers of most ocular adverse events were lower for the bromfenac group than for the placebo group. ...There were no serious ocular adverse events, and fewer …
The median time to resolution of ocular pain was 2 days (bromfenac) versus 5 days (placebo) (P<0.0001). Numbers of most ocular adv …
Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD.
Wyględowska-Promieńska D, Piotrowska-Gwóźdź A, Piotrowska-Seweryn A, Mazur-Piotrowska G. Wyględowska-Promieńska D, et al. Med Sci Monit. 2015 Dec 15;21:3906-12. doi: 10.12659/msm.895977. Med Sci Monit. 2015. PMID: 26667262 Free PMC article. Clinical Trial.
The aim of this study was to evaluate the effectiveness of aflibercept and bromfenac in the treatment of exudative AMD. MATERIAL AND METHODS The study was conducted on a group of 27 patients with exudative AMD who were administered intravitreal aflibercept and topical b …
The aim of this study was to evaluate the effectiveness of aflibercept and bromfenac in the treatment of exudative AMD. MATERIAL AND …
COMPARISON OF THE EFFECTS OF EIGHT DIFFERENT TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON REDUCING INTRAVITREAL INJECTION-INDUCED PAIN.
SakallioĞlu AK, Kaya S, Garİp R, Güçlü H. SakallioĞlu AK, et al. Retina. 2024 Jul 1;44(7):1196-1202. doi: 10.1097/IAE.0000000000004085. Retina. 2024. PMID: 38437826 Clinical Trial.
RESULTS: Nepafenac 0.3%, nepafenac 0.1%, and bromfenac 0.09% had the lowest scores, immediately after and after 6 hours, with no significant differences. ...CONCLUSION: Nepafenac 0.3%, nepafenac 0.1%, and bromfenac 0.09% were the most effective NSAIDs for pain reduc …
RESULTS: Nepafenac 0.3%, nepafenac 0.1%, and bromfenac 0.09% had the lowest scores, immediately after and after 6 hours, with no sign …
Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial.
Kim S, Ko BY, Koh JW, Kim EC, Kim HK, Shin YJ, Song JS, Lee DH, Lee JE, Lee HK, Chung SH, Kim HS. Kim S, et al. J Cataract Refract Surg. 2022 Jun 1;48(6):710-716. doi: 10.1097/j.jcrs.0000000000000841. Epub 2021 Oct 8. J Cataract Refract Surg. 2022. PMID: 34629379 Free PMC article. Clinical Trial.
METHOD: In 125 (250 eyes) patients who underwent cataract surgery, bromfenac sodium hydrate 0.1% (NSAID group) was applied twice a day in 1 eye, whereas the other eye was treated with fluorometholone 0.1% (steroid group), 4 times a day for 4 weeks postoperatively. ...Lower …
METHOD: In 125 (250 eyes) patients who underwent cataract surgery, bromfenac sodium hydrate 0.1% (NSAID group) was applied twice a da …
87 results